3rd Quarter - Report

AVENUE SOLUTIONS for FRESENIUS MEDICAL CARE NORTH AMERICA

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Proposed Rule - CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney Injury Dialysis (AKI) Payment, and ESRD Quality Incentive Program; Market Basket Update in CY 2027 ESRD PPS; Low Volume Payment Adjustment eligibility in CY 2027 ESRD PPS; Medicare forecast error adjustment in ESRD PPS

LobbyistCovered position, as disclosed
ELIZABETH MACDONALD BARNETT —
AIMEE LEWIS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2199 (119th), S. 1173 (119th), H.R. 6214 (119th), S. 2730 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.